Shionogi
![Orchid Pharma, GSK, Shionogi, cefiderocol, antibiotic, license, global access](https://pharmtales.com/wp-content/uploads/2023/09/Orchid-Pharma-to-produce-GSK-and-Shionogis-antibiotic-for-global-access.jpg)
Orchid Pharma to produce GSK and Shionogiās antibiotic for global access
Anika Sharma
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has secured a sublicense to manufacture the antibiotic cefiderocol. This development is ...
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has secured a sublicense to manufacture the antibiotic cefiderocol. This development is ...